These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 3039328

  • 1. Ampicillin/sulbactam (Unasyn).
    Med Lett Drugs Ther; 1987 Aug 28; 29(747):79-81. PubMed ID: 3039328
    [No Abstract] [Full Text] [Related]

  • 2. Enzyme-mediated resistance to beta-lactam antibiotics: a symposium on sulbactam/ampicillin. Cairo, Egypt, April 18-19, 1985.
    Rev Infect Dis; 1986 Aug 28; 8 Suppl 5():S465-650. PubMed ID: 3025995
    [No Abstract] [Full Text] [Related]

  • 3. Comparative clinical study of Sulbactam and ampicillin and clindamycin and tobramycin in infections of soft tissues.
    Stromberg BV, Reines HD, Hunt P.
    Surg Gynecol Obstet; 1986 Jun 28; 162(6):575-8. PubMed ID: 3012808
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetic and therapeutic trial of sultamicillin in acute sinusitis.
    Jones S, Yu VL, Johnson JT, Wagner RL, Kim HK.
    Antimicrob Agents Chemother; 1985 Dec 28; 28(6):832-3. PubMed ID: 3002247
    [Abstract] [Full Text] [Related]

  • 5. Clinical, bacteriological and pharmacokinetic results from an open trial of sultamicillin in patients with acute exacerbations of chronic bronchitis.
    Davies BI, Maesen FP, van Noord JA.
    J Antimicrob Chemother; 1984 Feb 28; 13(2):161-70. PubMed ID: 6323377
    [Abstract] [Full Text] [Related]

  • 6. The plasma kinetics of sulbactam-ampicillin administered to calves by the intramuscular and subcutaneous routes.
    Grimshaw WT, Colman PJ.
    Br Vet J; 1987 Feb 28; 143(4):361-8. PubMed ID: 3040163
    [No Abstract] [Full Text] [Related]

  • 7. A three-way crossover study to compare the pharmacokinetics and acceptability of sultamicillin at two dose levels with that of ampicillin.
    Hartley S, Wise R.
    J Antimicrob Chemother; 1982 Jul 28; 10(1):49-55. PubMed ID: 6286587
    [No Abstract] [Full Text] [Related]

  • 8. The parenteral kinetics of ampicillin/sulbactam in man.
    Foulds G, Knirsch AK, Stankewich JP, Weidler DR.
    Int J Clin Pharmacol Res; 1985 Jul 28; 5(2):79-86. PubMed ID: 2991150
    [Abstract] [Full Text] [Related]

  • 9. Sultamicillin (CP-49, 952): evaluation of two dosage schedules in urinary infection.
    Ball AP, Fox C, Ghosh D.
    J Antimicrob Chemother; 1984 Oct 28; 14(4):395-401. PubMed ID: 6094422
    [Abstract] [Full Text] [Related]

  • 10. Clinical efficacy and safety of sulbactam/ampicillin in patients suffering from chronic liver disease.
    Galante D, Esposito S, Barba D, Ruffilli MP.
    J Antimicrob Chemother; 1987 Apr 28; 19(4):527-32. PubMed ID: 3034850
    [Abstract] [Full Text] [Related]

  • 11. [Refractory respiratory tract infections. 7. Trends in the development of new chemotherapeutic agents for respiratory tract infections. c. Combinations of beta-lactam antibiotics and beta-lactamases inhibitors].
    Tamura M, Ito T.
    Nihon Rinsho; 1987 Mar 28; 45(3):583-7. PubMed ID: 3037135
    [No Abstract] [Full Text] [Related]

  • 12. Activity of sulbactam/ampicillin in screening and discriminative animal models of infection.
    English AR, Girard D, Cimochowski C, Faiella J, Retsema JA, Lynch JE.
    Rev Infect Dis; 1986 Mar 28; 8 Suppl 5():S535-42. PubMed ID: 3026002
    [Abstract] [Full Text] [Related]

  • 13. [Profile of a new antibiotic: the combination sulbactam/ampicillin].
    Barba D, Galante D, Esposito S, Giusti G.
    Recenti Prog Med; 1987 Jun 28; 78(6):274-83. PubMed ID: 3310152
    [No Abstract] [Full Text] [Related]

  • 14. A randomized controlled trial of ampicillin plus sulbactam vs. gentamicin plus clindamycin in the treatment of intraabdominal infections: a preliminary report. Study Group of Intraabdominal Infections.
    Rev Infect Dis; 1986 Jun 28; 8 Suppl 5():S583-8. PubMed ID: 2879345
    [Abstract] [Full Text] [Related]

  • 15. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS, Tosin I, Sejas L, Miranda E.
    Braz J Infect Dis; 2000 Feb 28; 4(1):22-8. PubMed ID: 10788842
    [Abstract] [Full Text] [Related]

  • 16. Sulbactam-containing beta-lactamase inhibitor combinations.
    Akova M.
    Clin Microbiol Infect; 2008 Jan 28; 14 Suppl 1():185-8. PubMed ID: 18154545
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of sequential treatment with parenteral sulbactam/ampicillin and oral sultamicillin for skeletal infections in children.
    Aronoff SC, Scoles PV, Makley JT, Jacobs MR, Blumer JL, Kalamchi A.
    Rev Infect Dis; 1986 Jan 28; 8 Suppl 5():S639-43. PubMed ID: 3026018
    [Abstract] [Full Text] [Related]

  • 18. [Comparative study on sultamicillin and bacampicillin in the treatment of respiratory tract infections].
    Kobayashi H, Takamura K, Kono K, Nihei T, Saito A, Nakayama I, Ujiie A, Yajima O, Tango M, Tomizawa M.
    Kansenshogaku Zasshi; 1985 Jul 28; 59(7):708-48. PubMed ID: 2997342
    [No Abstract] [Full Text] [Related]

  • 19. A non-comparative study of parenteral ampicillin and sulbactam in intra-thoracic and intra-abdominal infections.
    Mehtar S, Croft RJ, Hilas A.
    J Antimicrob Chemother; 1986 Mar 28; 17(3):389-96. PubMed ID: 3009384
    [Abstract] [Full Text] [Related]

  • 20. Sulbactam plus ampicillin: interim review of efficacy and safety for therapeutic and prophylactic use.
    Lees L, Milson JA, Knirsch AK, Greenhalgh K.
    Rev Infect Dis; 1986 Mar 28; 8 Suppl 5():S644-50. PubMed ID: 3026019
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.